Evidence map›Paper›PMID 42740914›Full record

ArticleInternational journal of pharmaceutics: X2026

Fabrication of vitamin B

Rui Chang, Yu Lu, Yiming Liu, Qian Gao, Xuewei Zhang, Yanan Zhang, Yutong Xing, Xue Yan, Chaoxing He, Huifeng Zhang and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of pharmaceutics: X, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rui ChangDepartment of Pharmaceutics, School of Pharmaceutical Sciences, Hebei Medical University, Shijiazhuang, China.
Yu LuDepartment of Pharmaceutics, School of Pharmaceutical Sciences, Hebei Medical University, Shijiazhuang, China.
Yiming LiuDepartment of Pharmaceutics, School of Pharmaceutical Sciences, Hebei Medical University, Shijiazhuang, China.
Qian GaoDepartment of Pharmaceutics, School of Pharmaceutical Sciences, Hebei Medical University, Shijiazhuang, China.
Xuewei ZhangDepartment of Pharmaceutics, School of Pharmaceutical Sciences, Hebei Medical University, Shijiazhuang, China.
Yanan ZhangDepartment of Pediatrics, The Second Hospital of Hebei Medical University, Hebei Key Laboratory of Rare Disease, Shijiazhuang, China.
Yutong XingDepartment of Pediatrics, The Second Hospital of Hebei Medical University, Hebei Key Laboratory of Rare Disease, Shijiazhuang, China.
Xue YanDepartment of Pediatrics, The Second Hospital of Hebei Medical University, Hebei Key Laboratory of Rare Disease, Shijiazhuang, China.
Chaoxing HeDepartment of Pharmaceutics, School of Pharmaceutical Sciences, Hebei Medical University, Shijiazhuang, China.
Huifeng ZhangDepartment of Pediatrics, The Second Hospital of Hebei Medical University, Hebei Key Laboratory of Rare Disease, Shijiazhuang, China.
Bai XiangDepartment of Pharmaceutics, School of Pharmaceutical Sciences, Hebei Medical University, Shijiazhuang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vitamin B

Indexed as

Methylmalonic acidemiaMicrofluidic technologyMultivesicular liposomesSustained releaseVitamin B12

Identifiers

PMID42740914
PMCPMC13572002

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.